Salivary SIgA responses to acute moderate-vigorous exercise in monophasic oral contraceptive users

Appl Physiol Nutr Metab. 2015 Sep;40(9):863-7. doi: 10.1139/apnm-2014-0468. Epub 2015 Apr 2.

Abstract

The purpose of this study was to examine the effect of oral contraceptive (OC) use on salivary secretory immunoglobulin A (SIgA) levels at rest and in response to an acute bout of moderate-vigorous exercise during 2 phases of the 4-week OC cycle corresponding to different phases of the synthetic menstrual cycle. Ten healthy active females completed a cycling at 70% peak oxygen uptake for 45 min at 2 time points of an OC cycle: during the equivalent in time to the mid-follicular phase (day 8 ± 2) and the mid-luteal phase (day 20 ± 2). Timed unstimulated saliva samples were obtained before, immediately postexercise, and 1 h postexercise and analyzed for salivary SIgA. Salivary SIgA secretion rate was 26% (95% confidence limits (CI) 6-46) lower at postexercise compared with pre-exercise during the synthetic follicular phase (p = 0.019) but no differences were observed during the synthetic luteal trial. Saliva flow rate was 11% (95% CI, 8-30) lower at postexercise compared with pre-exercise (main effect for time; p = 0.025). In conclusion, the pattern of salivary SIgA secretion rate response to moderate-vigorous exercise varies across the early and late phases of a monophasic OC cycle, with a transient reduction in salivary SIgA responses during the synthetic follicular phase. These findings indicate that monophasic OC use should be considered when assessing mucosal immune responses to acute exercise.

Keywords: aerobic exercise; contraceptifs oraux combinés monophasiques; cycle de contraception orale; estrogen; exercice aérobie; monophasic combined oral contraceptives; oral contraceptive cycle; symptômes des voies respiratoires supérieures; upper respiratory symptoms; œstrogènes.

MeSH terms

  • Contraceptives, Oral, Hormonal / therapeutic use*
  • Estradiol / metabolism
  • Exercise*
  • Female
  • Humans
  • Immunity, Mucosal / drug effects
  • Immunoglobulin A, Secretory / metabolism*
  • Menstrual Cycle / drug effects*
  • Menstrual Cycle / immunology
  • Menstrual Cycle / metabolism
  • Progesterone / metabolism
  • Saliva / drug effects*
  • Saliva / immunology
  • Saliva / metabolism
  • Salivary Glands / immunology
  • Salivary Glands / metabolism*
  • Time Factors
  • Young Adult

Substances

  • Contraceptives, Oral, Hormonal
  • Immunoglobulin A, Secretory
  • Progesterone
  • Estradiol